Md Nasrul Hoda

Author PubWeight™ 21.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 2009 1.83
2 Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 2005 1.48
3 Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res 2007 1.14
4 Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 2005 1.12
5 Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res 2006 1.10
6 Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 2010 1.05
7 Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol 2009 1.00
8 Remote limb perconditioning [corrected] and postconditioning: will it translate into a promising treatment for acute stroke? Stroke 2013 0.97
9 Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav 2006 0.96
10 Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. J Ethnopharmacol 2006 0.93
11 Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats. Brain Res 2013 0.91
12 Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment. Transl Stroke Res 2014 0.91
13 Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem Res 2011 0.88
14 Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment. Neurol Sci 2011 0.83
15 Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA. Transl Stroke Res 2015 0.81
16 Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats. Chem Biol Interact 2010 0.79
17 Application of oxidants to the spectrophotometric determination of amlodipine besylate in pharmaceutical formulations. Farmaco 2004 0.79
18 Spectrophotometric determination of verapamil hydrochloride in drug formulations with chloramine-T as oxidant. Anal Bioanal Chem 2002 0.77
19 Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats. Behav Pharmacol 2009 0.77
20 Amelioration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced behavioural dysfunction and oxidative stress by Pycnogenol in mouse model of Parkinson's disease. Behav Pharmacol 2010 0.77
21 Response to letter regarding article, "Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type". Stroke 2013 0.75
22 Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. Hum Exp Toxicol 2006 0.75
23 Spectrophotometric method for the determination of nifedipine with 4-(methylamino)phenol and potassium dichromate. Farmaco 2002 0.75
24 Differential effects upon brain and serum BDNF levels in rats as response to continuous and intermittent administration strategies of two second generation antipsychotics. Schizophr Res 2013 0.75